NTM

Across TCGA pan-cancer cohorts, NTM mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated NTM data layer compared with 27 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher NTM mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NTM expression acts as an unfavorable survival marker.

COAD, PDAC, and GBM are the cancer types where NTM mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	III,IV	0.826	1.000	.023	12	view →
PDAC	DFS	Quartile	All	0.568	0.797	.008	5	view →
GBM	OS	Tertile	All	0.277	0.623	.024	4	view →
LSCC	DFS	Quartile	III,IV	0.379	0.833	.011	4	view →
LUAD	OS	Quartile	All	0.524	0.872	.014	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

NTM–COAD (DFS)

Open the COAD breakdown →